MARY KAVANAGH BARKER M.D. NPI 1215908132

NPI Details

Mary Kavanagh Barker, M.D. is an internal medicine in Wellesley, MA with 34 years of experience. The provider is a physician who provides long-term, comprehensive care in the office and the hospital, managing both common and complex illness of adolescents, adults and the elderly. Internists are trained in the diagnosis and treatment of cancer, infections and diseases affecting the heart, blood, kidneys, joints and digestive, respiratory and vascular systems. They are also trained in the essentials of primary care internal medicine, which incorporates an understanding of disease prevention, wellness, substance abuse, mental health and effective treatment of common problems of the eyes, ears, skin, nervous system and reproductive organs. Mary Kavanagh Barker, M.D. NPI is 1215908132. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

Education
Medical School: VIRGINIA COMMONWEALTH UNIVERSITY, SCHOOL OF MEDICINE
Graduation Year:1992

The provider's business location address is:

230 WORCESTER ST
INTERNAL MEDICINE
WELLESLEY, MA
ZIP 02481-420
Phone: (781) 431-5220
Fax: (781) 431-5371

The NPI 1215908132 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
• Hemoglobin a1c level (HCPCS:83036)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Complete blood cell count (red cells, white blood cell, platelets), automated test (HCPCS:85027)
• Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
• Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit (HCPCS:G0439)
• Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
• Blood creatinine level (HCPCS:82565)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Injection, zoledronic acid, 1 mg (HCPCS:J3489)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Vitamin d-3 level (HCPCS:82306)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Bacterial colony count, urine (HCPCS:87086)
• Creatinine level to test for kidney function or muscle injury (HCPCS:82570)
• Urine microalbumin (protein) level (HCPCS:82043)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Influenza vaccine split virus, preservative free (HCPCS:90662)
• Liver enzyme (sgpt), level (HCPCS:84460)
• Transferrin (iron binding protein) level (HCPCS:84466)
• Iron level (HCPCS:83540)
• Ferritin (blood protein) level (HCPCS:82728)
• Blood potassium level (HCPCS:84132)
• Automated urinalysis test (HCPCS:81003)
• Thyroxine (thyroid chemical), free (HCPCS:84439)
• Administration of pneumococcal vaccine (HCPCS:G0009)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Blood sodium level (HCPCS:84295)
• Bacterial culture for aerobic isolates (HCPCS:87077)
• Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit (HCPCS:G0438)
• Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral), microdilution or agar dilution (HCPCS:87186)
• Parathormone (parathyroid hormone) level (HCPCS:83970)
• Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r (HCPCS:U0003)
• Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within (HCPCS:U0005)
• Calcium level, total (HCPCS:82310)
• Liver enzyme (sgot), level (HCPCS:84450)
• Infusion, normal saline solution, 250 cc (HCPCS:J7050)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Phosphate level (HCPCS:84100)
• Hepatitis c antibody screening, for individual at high risk and other covered indication(s) (HCPCS:G0472)
• Uric acid level, blood (HCPCS:84550)
• Pneumococcal vaccine, 23-valent (HCPCS:90732)
• Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use (HCPCS:90677)
• Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza (HCPCS:87428)
• Hepatitis c antibody measurement (HCPCS:86803)
• Blood glucose (sugar) level (HCPCS:82947)
• Testing for presence of drug, read by direct observation (HCPCS:80305)
• Prostate cancer screening; prostate specific antigen test (psa) (HCPCS:G0103)

The enumeration date for this NPI number is 1/30/2006 and was last updated on 10/22/2020.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.